Algeria Click here to download the Healthcare & Life Sciences Review Algeria 2019 report. Algeria, Africa’s largest country by area, stands as a promising investment destination for the global life sciences industry, with a sizeable local market and a growing number of multinationals choosing to base their regional operations out…
China Tony Au, general manager of AbbVie China, shares the key milestones for the affiliate in the past six years, the strong foundation he has built for AbbVie in China, the mission of AbbVie to be the most reliable pharmaceutical company in China, and the exciting pipeline of innovative products and…
Spain Javier Alvarado, general manager of Mundipharma Spain, discusses his current priorities and the innovation the company is bringing to the market through a diversified portfolio. Furthermore, he points out the importance of long-term strategic partnerships for the company´s success and his future aspirations for the affiliate. Of course, none…
Spain Sergio Serra Ripol, managing director of Tillotts Pharma Spain, highlights the challenges associated with setting up the affiliate and the strategic importance of Spain as Tillotts grows its European footprint. Furthermore, he gives an insight into the importance of relationships in building the company’s network and his vision for the…
Top 10 Geoffrey Guy, David Meek, Tae Han Kim, Pierre Moustial, Vivek Sharma, Antonio Portela and many other remarkable people that are shaping the global life sciences industry shared with PharmaBoardroom valuable insights on the companies they lead and their vision for the future. Geoffrey Guy Geoffrey Guy is the chairman and founder…
Malaysia American medtech giant Baxter and pan-Asian healthcare service provider Zuellig Pharma have been collaborating in Malaysia to increase the quality and quantity of care that can be given to patients in their own homes, generating significant cost-savings for the healthcare system and increasing patient-centricity. “[Home care] reduces costs significantly,…
Malaysia Robert Kruit, chief executive for Zuellig Malaysia and Brunei, discusses Zuellig’s plans to expand beyond distribution and diversify its offering in the healthcare sector, and how Zuellig’s investments into digital health, commercial solutions, and animal health further the goal of making healthcare more accessible. The pharmaceutical segment [in Malaysia]…
Spain LEO Pharma’s Paolo Cionini discusses recent structural changes in the dermatology specialist’s Europe South operations, the importance of Spain to the regional group, and the nation’s digital capabilities. The biggest need in Europe and the US is around new products and technologies in advanced therapies. LEO Pharma has undergone…
Malaysia Javed Ghulam, CEO of AJ Research & Pharma, offers insights into the dynamic pharma industry in Malaysia and what it takes to be a competitive player in the region. Being part of AJ Pharmaceuticals Holdings, what is the scope of operations specific to AJ Research & Pharma? AJ Research…
Hong Kong Zuellig Pharma’s Andi Umbricht discusses the distributor’s deep commitment to Asia, the adoption of new technologies, and emerging trends within the Hong Kong and Asian distribution markets. Zuellig Pharma has a long tradition in Asia. What capabilities have you developed over the years in the region? Zuellig Pharma started operations…
Algeria Essam Farouk, President of MS Pharma provides insights on the success of its local manufacturing operations in Algeria, and the country’s potential to become an export hub. What recent changes have taken place within the MS Pharma group? We are planning expansions both inside and outside the Middle East and…
Algeria Malika Benmouffok, Algeria country manager of Tabuk Pharmaceuticals, explains the Saudi company’s story in Algeria, its partnership strategy and the disruptiveness of recent import restrictions. Can you start by introducing Tabuk and Tabuk’s story here in Algeria? We arrived in Algeria in 1997 with imports only. Then Tabuk partnered with…
See our Cookie Privacy Policy Here